Nausea News and Research

RSS

Nausea is the sensation of unease and discomfort in the upper stomach and head with an urge to vomit. An attack of nausea is known as a qualm.

Arizona advisory on tick removal

As hotter temperatures draw Arizonans to the state’s high country, Department of Health Services Director Catherine Eden advised residents to take precautions against tick bites because some ticks carry germs that cause disease, including Rocky Mountain spotted fever.

11 Jun 2004

Docetaxel decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy

Johns Hopkins Kimmel Cancer Center clinicians were among those at leading institutions that have completed a three-year international study showing that docetaxel, a drug made from yew tree needles, decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy.

11 Jun 2004

America's first two WNV encephalitis cases of 2004 respond to treatment

GenoMed, Inc. has announced that the country's second case of West Nile virus encephalitis has responded promptly to its treatment approach. So far, GenoMed's treatment is showing a 100% response rate among 13 immunocompetent patients. The sooner the treatment is instituted, the more rapid and more complete the response.

10 Jun 2004

Drug may benefit patients suffering deep scarring after radiation treatment

Cancer patients who suffer from a progressive, deep scarring of tissue following radiation treatment might benefit from a drug that’s FDA-approved to treat vascular disease, according to a University of Rochester study published in this month’s Journal of Clinical Oncology.

10 Jun 2004

Genetic link between hormones and migraine

Director of the Genomics Research Centre Professor Lyn Griffiths and her team of researchers at Griffith University have identified a genetic link between hormones and migraine.

9 Jun 2004

Alfalfa sprouts recalled due to possible health risk

The Food and Drug Administration has been alerted that Sprouters Northwest, Inc. of Kent Washington is recalling 2, 3, and 5 lbs. institutional trays of its raw alfalfa sprouts sent to various food institutions because they may be linked to a recent increase in Salmonellosis in Oregon and Washington State.

5 Jun 2004

Exenatide shows significant improvements in glucose control for people With type 2 diabetes

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company have presented detailed 30-week data from two of the three pivotal Phase 3 studies of exenatide during a late-breaking session at the American Diabetes Association's (ADA) 64th Scientific Sessions in Orlando, Florida.

5 Jun 2004

Drug Tarceva improves survival chance for patients with advanced lung cancer

Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).

5 Jun 2004

New generation drug therapy targets the individual

The days of ‘one size fits all’ medicines may soon be a thing of the past for people undergoing radical drug therapies for chronic or serious illnesses.

5 Jun 2004

FDA investigates school lunch illness in Massachusetts

The U.S. Food and Drug Administration (FDA), the Massachusetts Department of Public Health and the U.S. Centers for Disease Control and Prevention are actively investigating what may have caused four outbreaks of illnesses in children related to meals served at several schools in Massachusetts.

3 Jun 2004

Anti-inflammatory medicine Roflumilast improved lung function in patients with chronic obstructive pulmonary disease

ALTANA AG’s investigational anti-inflammatory medicine roflumilast improved lung function in patients with Chronic Obstructive Pulmonary Disease (COPD) according to a placebo controlled study presented at the annual meeting of the American Thoracic Society (ATS).

25 May 2004

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Results from an ongoing surveillance study, PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology of the Ketolide Telithromycin – United States) Year 2 (2001-2002), suggest that KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates, including those resistant to other antimicrobial agents.

24 May 2004

Significant symptom relief reported in clinical trial patients with irritable bowel syndrome

Solvay Pharmaceuticals unveiled this week results from a six-month study of both male and female patients and from a subgroup analysis of males with Irritable Bowel Syndrome with Diarrhea predominance (IBS-D).

24 May 2004

FDA issues gastrointestinal illness alert regarding raw basil in Texas and Illinois

The FDA is issuing an alert to consumers that two outbreak clusters of a gastrointestinal illness known as cyclosporiasis may be associated with raw basil and mesculin/spring mix salad served in Texas and Illinois. The agency is working with the U.S. Centers for Disease Control and Prevention and state and other health authorities to determine the cause and scope of the problem.

21 May 2004

$First drug approved for hormone refractory prostate cancer that has shown a survival benefit$

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

The the Food and Drug Administration (FDA) approved Taxotere (docetaxel), injection in combination with prednisone ( a steroid), for the treatment of patients with advanced metastatic prostate cancer. This is the first drug approved for hormone refractory prostate cancer that has shown a survival benefit.

19 May 2004

FDA approves new drug for bone marrow disease

The Food and Drug Administration (FDA) today announced the approval of Vidaza (azacitidine) injection, the first effective treatment for patients with Myelodysplastic Syndrome (MDS). The product was given Fast Track Status and a priority review.

19 May 2004

Interventional radiologists now are able to treat using minimally invasive procedures

Interventional radiologists at Temple University Hospital now are able to treat many patients with minimally invasive procedures not available only a few years ago. “Conditions that used to require extensive surgery now take an hour or less, and patients leave with a bandaid and walk home,” says Gary Cohen, M.D., Section Chief of Interventional Radiology and Vice Chairman of Radiology. “How can you beat that?”

17 May 2004

Wyeth gets FDA approval for a novel protein device that enhances bone healing

Wyeth have announced that the FDA has approved rhBMP-2/ACS (recombinant human Bone Morphogenetic Protein-2/Absorbable Collagen Sponge), a novel protein device that enhances bone healing, for use in the treatment of acute, open tibia shaft fractures in adults.

3 May 2004

A popular supplement, coenzyme Q10 (CoQ10), may help prevent migraine

Migraine patients who took 100 mg three times a day of CoQ10—which acts as the body’s energy producer—had fewer attacks in three months than those who took a placebo. The participants taking CoQ10 also had fewer days with a headache and fewer days with nausea.

28 Apr 2004

Study shows MIRAPEX(R) (pramipexole) relieves patients with restless legs syndrome

Results from a large-scale, randomized, double-blind study show MIRAPEX(R) (pramipexole) provides rapid relief in patients with restless legs syndrome (RLS).

28 Apr 2004

Nausea News and Research

Further Reading

Arizona advisory on tick removal

Docetaxel decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy

America's first two WNV encephalitis cases of 2004 respond to treatment

Drug may benefit patients suffering deep scarring after radiation treatment

Genetic link between hormones and migraine

Alfalfa sprouts recalled due to possible health risk

Exenatide shows significant improvements in glucose control for people With type 2 diabetes

Drug Tarceva improves survival chance for patients with advanced lung cancer

New generation drug therapy targets the individual

FDA investigates school lunch illness in Massachusetts

Anti-inflammatory medicine Roflumilast improved lung function in patients with chronic obstructive pulmonary disease

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Significant symptom relief reported in clinical trial patients with irritable bowel syndrome

FDA issues gastrointestinal illness alert regarding raw basil in Texas and Illinois

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

FDA approves new drug for bone marrow disease

Interventional radiologists now are able to treat using minimally invasive procedures

Wyeth gets FDA approval for a novel protein device that enhances bone healing

A popular supplement, coenzyme Q10 (CoQ10), may help prevent migraine

Study shows MIRAPEX(R) (pramipexole) relieves patients with restless legs syndrome

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Latest News